Plancorp LLC
VRTX icon

Plancorp LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Plancorp LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$254K Buy
+455
New +$233K 0.01% 387
2025
Q2 		– Sell
-469
Closed -$227K – 389
2025
Q1 		$227K Buy
+469
New +$219K 0.01% 322
2024
Q4 		– Sell
-432
Closed -$201K – 337
2024
Q3 		$201K Buy
+432
New +$208K 0.01% 304

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Plancorp LLC's VRTX Position: Q3 2026 in Review

Plancorp LLC opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 455 shares worth $254K. The stake represents 0.01% of the portfolio and ranks #387 among its holdings. This is a return to the name: Plancorp LLC previously reported a position in VRTX as recently as Q1 2025.

Plancorp LLC first reported a position in VRTX in Q3 2024 and has held it in 3 quarters since. 1,083 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Plancorp LLC held 455 shares of Vertex Pharmaceuticals worth $254K as of Q3 2026.
  • Vertex Pharmaceuticals was a new Plancorp LLC position in Q3 2026.
  • Vertex Pharmaceuticals made up 0.01% of Plancorp LLC's portfolio in Q3 2026, its #387 holding.
  • Plancorp LLC first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • 1,083 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Plancorp LLC's 13F filing for Q3 2026, filed 3 Nov 2026.